Welcome to our dedicated page for Ulta Beauty SEC filings (Ticker: ULTA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ulta Beauty filings document the regulatory record for a Delaware operating company whose common stock trades on the Nasdaq Global Select Market under ULTA. Material-event reports cover financial results, guidance releases, retail partnership disclosures, executive leadership changes, board appointments and executive severance arrangements.
Proxy materials describe annual meeting matters, director elections, board committee structure, executive compensation, equity awards and pay-versus-performance disclosures. The filing record also provides formal disclosure of governance practices, officer compensation arrangements, registered securities and other corporate actions tied to Ulta Beauty’s specialty beauty retail business.
Ulta Beauty, Inc. reported that its Chief Human Resources Officer, Anita Jane Ryan, acquired 644 shares of common stock on February 12, 2026 through a performance-based equity award. The shares were issued at a price of $0 per share and increased her directly held stake to 7,967 shares.
The 644 shares relate to performance-based restricted share units granted on March 31, 2023 under Ulta Beauty’s 2011 Incentive Award Plan. Each unit represents one share of common stock and vested after certain performance goals were met and service-based conditions that run through March 15, 2026, with the compensation committee certifying on February 12, 2026 that the performance goals were satisfied.
Ulta Beauty, Inc. has put a new Executive Severance Plan in place for its executive officers. This plan applies when an executive is involuntarily terminated without “Cause,” as defined in the plan, and not in connection with a change in control, death, or disability, which are handled separately.
The company’s existing Executive Change in Control and Severance Plan, originally adopted in 2017, will continue to govern qualifying terminations that occur in connection with a change in control. The new severance plan replaces prior severance protections for executive officers, such as individual letters or other plans, except for protections that are specifically provided under the change in control plan.
Ulta Beauty, Inc. director Catherine Ann Halligan reported a change in her holdings of the company’s common stock. On 12/15/2025, a transaction coded “G” (a bona fide gift) shows that 340 shares of common stock were disposed of at a price of $0, indicating the shares were given away rather than sold. Following this gift, she beneficially owns 2,060 shares of Ulta Beauty common stock in direct ownership.
Ulta Beauty (ULTA) appointed Christopher DelOrefice as Chief Financial Officer, and as principal financial and accounting officer, effective December 5, 2025. He joins from Becton Dickinson, following more than two decades in senior finance roles at Johnson & Johnson. Interim CFO Christopher Lialios will return to his role as Senior Vice President, Controller.
Compensation includes a $980,000 annual base salary. Beginning in fiscal 2026, he is eligible for an annual cash incentive with a target of 125% of base salary (maximum 200% of target) and participation in the long‑term incentive program with a 2026 target grant value of 450% of base salary (expected March 2026), split evenly between RSUs vesting March 15, 2029, and stock options vesting annually starting March 15, 2027. Sign‑on awards include $1,000,000 cash (subject to one‑year repayment if he resigns or is terminated for cause), RSUs valued at $1,100,000 vesting on the first anniversary, and RSUs valued at $2,200,000 vesting on the second anniversary, expected in December 2025. He will receive relocation support for 12 months and up to $20,000 in attorneys’ fees.
Form 144 notice for Ulta Beauty (ULTA) shows a proposed sale of 690 shares of common stock to be executed through Charles Schwab on 09/19/2025 with an aggregate market value of $369,019. The filer reports those 690 shares were acquired the same day via an employee stock option exercise and the exercise was a cashless exercise with broker payment.
The filing also discloses a prior sale by the same account: 1,525 shares sold on 09/11/2025 for gross proceeds of $791,994. The notice includes the standard representation that the seller is not aware of any material nonpublic information about the issuer.
Form 144 notice for Ulta Beauty (ULTA) shows a proposed sale of 690 shares of common stock to be executed through Charles Schwab on 09/19/2025 with an aggregate market value of $369,019. The filer reports those 690 shares were acquired the same day via an employee stock option exercise and the exercise was a cashless exercise with broker payment.
The filing also discloses a prior sale by the same account: 1,525 shares sold on 09/11/2025 for gross proceeds of $791,994. The notice includes the standard representation that the seller is not aware of any material nonpublic information about the issuer.
Ulta Beauty, Inc. (ULTA) filed a Form 144 notifying intent to sell securities under Rule 144. The filer intends to sell 1,525 shares of common stock on or about 09/11/2025 through Charles Schwab & Co., Inc. The reported aggregate market value of the shares to be sold is $791,994.00, with 44,838,364 shares outstanding. The shares were acquired the same day, 09/11/2025, via an employee stock option exercise, and the payment method is listed as a broker payment for cashless exercise. No sales by the reporting person in the prior three months were reported. The notice includes the usual certification that the seller is not aware of undisclosed material adverse information about the issuer.
Mike C. Smith, a director of Ulta Beauty, Inc. (ULTA), reported a sale of 500 shares of ULTA common stock on 09/04/2025 at a reported price of $528.43 per share. After the sale, the filing shows Mr. Smith beneficially owned 2,263 shares directly. The Form 4 is signed by an attorney-in-fact on 09/08/2025.
Form 144 filed for ULTA. The filer notifies a proposed sale of 500 shares of Ulta Beauty common stock through Charles Schwab & Co., Inc. with an aggregate market value of $264,215.00, an approximate sale date of 09/04/2025, and the securities exchange listed as NASDAQ. The filing shows total shares outstanding of 44,838,364. The 500 shares were acquired as equity compensation: 67 shares lapsed 09/19/2020 and 433 shares lapsed 06/03/2021, both from Ulta Beauty. The filer reports no securities sold in the past three months and signs the notice attesting no undisclosed material adverse information.
Stephanie Lee Landry, a director of Ulta Beauty, Inc. (ULTA), acquired 277 restricted stock units on 09/01/2025. The Form 4 reports the grant as an acquisition (code A) at no cash price ($0). The filing shows 277 shares beneficially owned following the transaction in a direct ownership form. The RSUs are described in the explanation as vesting 100% on 09/01/2026. The Form 4 was signed by an attorney-in-fact on 09/03/2025. No derivatives, option exercises, cash purchases, or sales are reported in this filing.
Ulta Beauty director Martin Brok received a grant of 277 restricted stock units (RSUs) on 09/01/2025, recorded as a non‑derivative acquisition at a grant price of $0. After the grant, the reporting person beneficially owned 1,277 shares of Ulta Beauty common stock in a direct form. The RSUs vest 100% on 09/01/2026, per the form's explanation. The Form 4 was filed by a single reporting person and signed by an attorney‑in‑fact on 09/03/2025. This disclosure documents a routine equity compensation award to a director and the resulting change in direct beneficial ownership.